Biologics and Biosimilars Manufacturing Post Master's Certificate Postgraduate Programme By Temple University |TopUniversities
Subject Ranking

# 351-400QS Subject Rankings

Application Deadline

15 Jan, 2026Application Deadline

Main Subject Area

Pharmacy and PharmacologyMain Subject Area

Programme overview

Main Subject

Pharmacy and Pharmacology

Degree

Other

Study Level

Masters

Study Mode

On Campus

We offer two certificates in biologics and biosimilars. The Post-Master's Certificate in Biologics and Biosimilars: Manufacturing provides a broad overview of the technical aspects of biologics manufacturing.


If you seek a program with a greater emphasis on regulatory aspects related to biologics and biosimilars, review the brochure for the Post-Master's Certificate in Biologics and Biosimilars: Regulatory Aspects.


Ever since the first biopharmaceutical product (recombinant human insulin) was approved in 1982, products derived through biotechnology have provided medical advances that include cell and gene therapies, therapeutic monoclonal antibodies, cancer vaccines, cytokines, antisense technology, interference RNA, and growth factors.


Temple's Post -Master's Certificate in Biologics and Biosimilars Manufacturing focuses on CMC aspects in the development and manufacture of these products, preparing students for positions in the biopharmaceutical industry and sharpening the skills and knowledge of those already working in this field.


This five-course certificate enables students to become fluent in the methods used in the discovery of biopharmaceutical products, including materials sourcing and testing requirements. Technologies and unique considerations associated with the manufacture of biopharmaceutical products are discussed.

Programme overview

Main Subject

Pharmacy and Pharmacology

Degree

Other

Study Level

Masters

Study Mode

On Campus

We offer two certificates in biologics and biosimilars. The Post-Master's Certificate in Biologics and Biosimilars: Manufacturing provides a broad overview of the technical aspects of biologics manufacturing.


If you seek a program with a greater emphasis on regulatory aspects related to biologics and biosimilars, review the brochure for the Post-Master's Certificate in Biologics and Biosimilars: Regulatory Aspects.


Ever since the first biopharmaceutical product (recombinant human insulin) was approved in 1982, products derived through biotechnology have provided medical advances that include cell and gene therapies, therapeutic monoclonal antibodies, cancer vaccines, cytokines, antisense technology, interference RNA, and growth factors.


Temple's Post -Master's Certificate in Biologics and Biosimilars Manufacturing focuses on CMC aspects in the development and manufacture of these products, preparing students for positions in the biopharmaceutical industry and sharpening the skills and knowledge of those already working in this field.


This five-course certificate enables students to become fluent in the methods used in the discovery of biopharmaceutical products, including materials sourcing and testing requirements. Technologies and unique considerations associated with the manufacture of biopharmaceutical products are discussed.

Admission Requirements

15 Jan 2026

Scholarships

Selecting the right scholarship can be a daunting process. With countless options available, students often find themselves overwhelmed and confused. The decision can be especially stressful for those facing financial constraints or pursuing specific academic or career goals.

To help students navigate this challenging process, we recommend the following articles:

More programmes from the university

Postgrad Programmes 602